Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Brett

Showing results (91-100 of 111) with videos related to

Pageof 12
Sort By:
The Lancet Regional Health. Western Pacific|June 8, 2026
A comprehensive overview of paracetamol poisoning admissions and long-term outcomes in New South Wales, Australia: a retrospective linked data cohort (PAVLOVA-3)Annabelle S Chidiac, Nicholas A Buckley, Firouzeh Noghrehchi, et al.
Environmental Science & Technology|May 19, 2021
An Automated Methodology for Non-targeted Compositional Analysis of Small Molecules in High Complexity Environmental Matrices Using Coupled Ultra Performance Liquid Chromatography Orbitrap Mass SpectrometryKelly L Pereira, Martyn W Ward, John L Wilkinson, et al.
Emergency Medicine Australasia : EMA|April 1, 2024
Trends in reported GHB-related presentations to Sydney emergency departments between 2012 and 2021Oliver Harris, Krista J Siefried, Angela Chiew, et al.
Addiction (Abingdon, England)|October 9, 2025
Emergency department presentations, hospitalisations and police seizure data related to gamma-hydroxybutyrate (GHB) in New South Wales, Australia, from 2015 to 2024Krista J Siefried, Janette L Smith, Christine A Harvey, et al.
Plos One|October 3, 2022
Trial protocol of an open label pilot study of lisdexamfetamine for the treatment of acute methamphetamine withdrawalLiam S Acheson, Nadine Ezard, Nicholas Lintzeris, et al.
The International Journal on Drug Policy|March 13, 2024
Participant experiences in a pilot study for methamphetamine withdrawal treatment: Implications for retentionLiam S Acheson, Simon Clay, Rebecca McKetin, et al.
European Addiction Research|March 18, 2024
Measuring Objective and Subjective Sleep during Lisdexamfetamine Treatment of Acute Methamphetamine Withdrawal: A Feasibility StudyLiam S Acheson, Christopher Gordon, Rebecca McKetin, et al.
Drug and Alcohol Dependence|November 18, 2022
Lisdexamfetamine for the treatment of acute methamphetamine withdrawal: A pilot feasibility and safety trialLiam S Acheson, Nadine Ezard, Nicholas Lintzeris, et al.
Harm Reduction Journal|February 7, 2026
'A fine line between euphoria and death': a qualitative study exploring gamma-hydroxybutyrate (GHB) use among people who identify as heterosexual living in AustraliaKeaton Hudson-Buhagiar, Jonathan Brett, Alanah Spillane, et al.
Emergency Medicine Journal : EMJ|October 1, 2025
A 3-year experience of an Australian short-stay Psychiatric, Alcohol and Non-prescription Drug Assessment Unit: unit activity and the patient experienceJane Ellen Carland, Yvonne Nguyen, Hannah Paul, et al.
Pageof 12

Showing results (91-100 of 111) with videos related to

Sort By:
Pageof 12
The Lancet Regional Health. Western Pacific|June 8, 2026
A comprehensive overview of paracetamol poisoning admissions and long-term outcomes in New South Wales, Australia: a retrospective linked data cohort (PAVLOVA-3)Annabelle S Chidiac, Nicholas A Buckley, Firouzeh Noghrehchi, et al.
Environmental Science & Technology|May 19, 2021
An Automated Methodology for Non-targeted Compositional Analysis of Small Molecules in High Complexity Environmental Matrices Using Coupled Ultra Performance Liquid Chromatography Orbitrap Mass SpectrometryKelly L Pereira, Martyn W Ward, John L Wilkinson, et al.
Emergency Medicine Australasia : EMA|April 1, 2024
Trends in reported GHB-related presentations to Sydney emergency departments between 2012 and 2021Oliver Harris, Krista J Siefried, Angela Chiew, et al.
Addiction (Abingdon, England)|October 9, 2025
Emergency department presentations, hospitalisations and police seizure data related to gamma-hydroxybutyrate (GHB) in New South Wales, Australia, from 2015 to 2024Krista J Siefried, Janette L Smith, Christine A Harvey, et al.
Plos One|October 3, 2022
Trial protocol of an open label pilot study of lisdexamfetamine for the treatment of acute methamphetamine withdrawalLiam S Acheson, Nadine Ezard, Nicholas Lintzeris, et al.
The International Journal on Drug Policy|March 13, 2024
Participant experiences in a pilot study for methamphetamine withdrawal treatment: Implications for retentionLiam S Acheson, Simon Clay, Rebecca McKetin, et al.
European Addiction Research|March 18, 2024
Measuring Objective and Subjective Sleep during Lisdexamfetamine Treatment of Acute Methamphetamine Withdrawal: A Feasibility StudyLiam S Acheson, Christopher Gordon, Rebecca McKetin, et al.
Drug and Alcohol Dependence|November 18, 2022
Lisdexamfetamine for the treatment of acute methamphetamine withdrawal: A pilot feasibility and safety trialLiam S Acheson, Nadine Ezard, Nicholas Lintzeris, et al.
Harm Reduction Journal|February 7, 2026
'A fine line between euphoria and death': a qualitative study exploring gamma-hydroxybutyrate (GHB) use among people who identify as heterosexual living in AustraliaKeaton Hudson-Buhagiar, Jonathan Brett, Alanah Spillane, et al.
Emergency Medicine Journal : EMJ|October 1, 2025
A 3-year experience of an Australian short-stay Psychiatric, Alcohol and Non-prescription Drug Assessment Unit: unit activity and the patient experienceJane Ellen Carland, Yvonne Nguyen, Hannah Paul, et al.
Pageof 12